Skip to main content
Clinical Trials/NL-OMON42622
NL-OMON42622
Completed
Phase 2

ociceptive-Level (NoL)-guided analgesia versus standard practice during general remifentanil/propofol anesthesia in ASA 1-3 patients - NoLA

eids Universitair Medisch Centrum0 sites80 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
anesthesie/chirurgie
Sponsor
eids Universitair Medisch Centrum
Enrollment
80
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 22, 2017
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age: 18\-80 years;
  • 2\. ASA I\-II\-III
  • 3\. Elective open abdominal surgery or laparoscopic assisted abdominal surgery.

Exclusion Criteria

  • 1\. Unable to give written informed consent;
  • 2\. Use of epidural analgesia or local anesthesia (eg. transversus abdominal plain block, TAP block)
  • 3\. Non\-elective surgery
  • 4\. Pregnancy/lactation;
  • 5\. BMI \> 35 kg/m2;
  • 6\. Uncontrolled preoperative hypo\- or hypertension (Mean arterial pressure \< 60 mmHg or \> 100 mmHg)
  • 7\. Preoperative Heart rate \< 45/min or \> 90/min;
  • 8\. Central nervous system disorder (neurologic/head trauma/uncontrolled epileptic seizures);
  • 9\. Illicit substance or alcohol abuse within 30 days;
  • 10\. Chronic use of pain medication within 30 days;

Outcomes

Primary Outcomes

Not specified

Similar Trials